Abstract
Ciliated cell markers expressed in epithelial ovarian cancers (EOC) are associated with improved survival. We examined the distribution of cells expressing ciliated cell markers in various EOC histologies and stages. Immunohistochemistry and/or multiplex immunofluorescence were used to determine the expression of FOXJ1 and/or CAPS (ciliated cell markers) in tissue microarrays including 4 normal fallopian tubes, 6 normal endometria, 16 cystadenomas, 25 borderline tumors, 21 low-grade carcinomas, and 118 high-grade carcinomas (HGSOC) (46 serous, 29 endometrioid, 30 clear cell, 13 mucinous). CAPS+ cells were observed in normal fallopian tubes and endometria and in ~85% of serous benign and borderline tumors and low-grade carcinomas but only in <40% of HGSOC. mRNA data from an independent cohort showed higher FOXJ1 and CAPS expression in serous borderline tumors and low-grade carcinomas compared to HGSOC. In HGSOC, ciliated cell-positive markers were observed in 52% primary tumors compared to 26% of patient-matched synchronous metastases, and 24% metachronous metastases (p = 0.009). mRNA data from an independent HGSOC cohort showed lower levels of CAPS in metastases than in primary tumors (p = 0.03). Overall, the study revealed that ciliated cells were less common in mucinous EOC, the percentage of ciliated cell marker-positive cases decreased with increasing grade, and the percentage of ciliated cells decreased in HGSOC metastases compared to patient-matched primary tumors.
Funder
United States Department of Veterans Affairs Merit
Office of the Assistant Secretary of Defense for Health Affairs through the Ovarian Cancer Research Program
Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence
Sandy Rollman Ovarian Cancer Foundation
Annenberg Foundation
Tina’s Wish Foundation
Reference32 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022
2. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors);Harter;Int. J. Gynecol. Cancer,2014
3. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded;Kurman;Am. J. Pathol.,2016
4. Coan, M., Rampioni Vinciguerra, G.L., Cesaratto, L., Gardenal, E., Bianchet, R., Dassi, E., Vecchione, A., Baldassarre, G., Spizzo, R., and Nicoloso, M.S. (2018). Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer. Int. J. Mol. Sci., 19.
5. Extraovarian peritoneal serous papillary carcinoma. A Clin. icopathologic study of 31 cases;Dalrymple;Cancer,1989
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献